W
W. Peter Hofmann
Researcher at Goethe University Frankfurt
Publications - 12
Citations - 2378
W. Peter Hofmann is an academic researcher from Goethe University Frankfurt. The author has contributed to research in topics: Medicine & Cirrhosis. The author has an hindex of 7, co-authored 7 publications receiving 2246 citations. Previous affiliations of W. Peter Hofmann include Saarland University.
Papers
More filters
Journal ArticleDOI
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.
Adriaan J. van der Meer,Bart J. Veldt,Jordan J. Feld,Heiner Wedemeyer,Jean-François Dufour,Frank Lammert,Andres Duarte-Rojo,E. Jenny Heathcote,Michael P. Manns,L. Kuske,Stefan Zeuzem,W. Peter Hofmann,Robert J. de Knegt,Bettina E. Hansen,Harry L.A. Janssen +14 more
TL;DR: Among patients with chronic HCV infection and advanced hepatic fibrosis, sustained virological response to interferon-based treatment was associated with lower all-cause mortality.
Journal ArticleDOI
Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis
Bart J. Veldt,E. Jenny Heathcote,Heiner Wedemeyer,Juerg Reichen,W. Peter Hofmann,Stefan Zeuzem,Michael P. Manns,Bettina E. Hansen,Solko W. Schalm,Harry L.A. Janssen +9 more
TL;DR: It was found that sustained virologic response decreased patients' hazard of liver failure and was associated with a reduction in fibrosis in patients with chronic hepatitis C and advanced fibrosis who did and did not have sustained virolic response to treatment.
Journal ArticleDOI
Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
Bart J. Veldt,Wendong Chen,E. Jenny Heathcote,Heiner Wedemeyer,Juerg Reichen,W. Peter Hofmann,Robert J. de Knegt,Stefan Zeuzem,Michael P. Manns,Bettina E. Hansen,Solko W. Schalm,Harry L.A. Janssen +11 more
TL;DR: For patients with chronic hepatitis C and advanced cirrhosis, diabetes mellitus increases the risk of developing HCC.
Journal ArticleDOI
Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis.
Adriaan J. van der Meer,Raoel Maan,Bart J. Veldt,Jordan J. Feld,Heiner Wedemeyer,Jean-François Dufour,Frank Lammert,Andres Duarte-Rojo,Michael P. Manns,Stefan Zeuzem,W. Peter Hofmann,Robert J. de Knegt,Bettina E. Hansen,Harry La Janssen,Harry La Janssen +14 more
TL;DR: Assessment of changes in platelet counts after antiviral therapy among chronic HCV‐infected patients with advanced fibrosis found them to be low, reflecting decreased platelet count and splenomegaly.
Journal ArticleDOI
Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters
Adriaan J. van der Meer,Bettina E. Hansen,Giovanna Fattovich,Jordan J. Feld,Heiner Wedemeyer,Jean-François Dufour,Frank Lammert,Andres Duarte-Rojo,Michael P. Manns,D. Ieluzzi,Stefan Zeuzem,W. Peter Hofmann,Robert J. de Knegt,Bart J. Veldt,Harry L.A. Janssen,Harry L.A. Janssen +15 more
TL;DR: Prognosis of patients with chronic HCV infection and compensated advanced liver disease can be accurately assessed with risk scores including readily available objective clinical parameters.